← Back to patent-cliff list
LV-232
Tier C — Watch / tradeLV-232
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：5-HT3
Indications (approved)：Depressive disorder, Major depressive disorder, Depression
Regional status
US
-
EU
-
China
Phase II
2025-04-03
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of LV-232?
Approved indications include: Depressive disorder, Major depressive disorder, Depression.
When does the LV-232 patent expire?
No public expiry year is available for LV-232 yet; this page updates once verified.
How do I get a quote for LV-232 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30